Farnesoid X receptor activation by the novel agonist TC-100 (3α, 7α, 11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid) preserves the intestinal barrier integrity and promotes intestinal microbial reshaping in a mouse model of obstructed bile acid flow

Autor: Marzano, M., Fosso, Bruno, Colliva, C., Notario, E., Passeri, D., Intranuovo, M., Gioiello, A., Adorini, L., Pesole, G., Pellicciari, R., Moschetta, A., Gadaleta, R.M.
Zdroj: In Biomedicine & Pharmacotherapy September 2022 153
Databáze: ScienceDirect
Externí odkaz: